Immunotherapy Centers of Research Excellence (imCORE®)

Improves impact of cancer immunotherapies via a collaborative research network

Immunotherapy Centers of Research Excellence (imCORE®) is a global academic-industry partnership uniting experts from across the world committed to advancing cancer immunotherapy research for better patient outcomes. Experts and their institutions share ideas, data, and technologies to accelerate basic and clinical research in cancer immunotherapy, aiming to extend and improve the benefits to more patients.

imCORE® is funded by Roche.